戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 by transfection with a constitutively active MAP kinase kinase 1.
2 158780 potently inhibited the LPA-stimulated MAP kinase kinase 1/2 (MKK1/2) activation and EGF recept
3            The in vivo administration of the MAP kinase kinase 1/2 inhibitor U0126 [1,4-diamino-2,3-d
4 ted protein kinases 1 and 2 (ERK1, ERK2) and MAP kinase kinases 1 and 2 (MKK1, MKK2), is well-known t
5 , an inhibitor of mitogen-activated protein (MAP) kinase kinase 1 and 2 (MEK1/2) that blocks phosphor
6  of C-Raf and the mitogen-activated protein (MAP) kinase kinases 1 and 2 (MEK1/2).
7 osphorylation and p90 ribosomal S6 kinase 2, MAP kinase kinase 1, and Raf-1 activities were increased
8              Since the only known targets of MAP kinase kinase-1 are Erk1 and Erk2, these findings ar
9 ion of mKsr-1 and mitogen-activated protein (MAP) kinase kinase 1 (MAPKK-1 or MEK-1).
10 it, respectively, mitogen-activated protein (MAP) kinase kinase 1 (MEK 1) and calcineurin, to determi
11                        The transfection of a MAP kinase kinase 1 (MEK1) dominant negative mutant cDNA
12 induced phenotype, we utilized the selective MAP kinase kinase 1 (MEK1) inhibitor, PD 098059.
13 tion, PD098059, a synthetic inhibitor of the MAP kinase kinase 1 (MEK1) was employed.
14                       UO126, an inhibitor of MAP kinase kinase 1 (MEK1), suppressed focal adhesion ta
15       We report that cdk5 phosphorylates the MAP kinase kinase-1 (MEK1) in vivo as well as the Ras-ac
16               Pretreatment of cells with the MAP kinase kinase-1 (MEK1) inhibitor PD 98059 blocked IL
17 We show that both mitogen-activated protein (MAP) kinase kinase 1 (MEK1) and MAP kinase kinase 2 (MEK
18  MNK1 activation is blocked by inhibitors of MAP kinase kinase 1 (Mkk1) and p38, demonstrating that M
19 transfection of constitutively active mutant MAP kinase kinase 1 (MKK1) enhanced endogenous topoisome
20 e and constitutively active mutants of human MAP kinase kinase-1 (MKK1) were analyzed by deuterium ex
21              Conversely, a dominant-negative MAP kinase kinase 1 mutant decreased adhesiveness and st
22                               In addition, a MAP kinase kinase 1 specific inhibitor blocked the expan
23                 Upon dual phosphorylation by MAP kinase kinase 1, the dynamics of assigned methyls in
24         Coinjection of constitutively active MAP kinase kinase-1, which opposes XCL100's effects on M

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。